H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) dropped 49.5% during mid-day trading on Thursday . The company traded as low as $2.02 and last traded at $2.02. Approximately 400 shares were traded during mid-day trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Trading Down 49.5 %
The firm’s fifty day moving average is $2.02 and its 200 day moving average is $2.02.
About H-CYTE
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
Further Reading
- Five stocks we like better than H-CYTE
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What is the Nikkei 225 index?
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- 3 Stocks to Consider Buying in October
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
